Scarica l'app Stockscreener
1.40
3.45%
-0.05
Dopo l'orario di chiusura:
1.40
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché MBIO Giù?
Forum
Previsione
Frazionamento azionario
Mustang Bio Inc Borsa (MBIO) Ultime notizie
Car T Cell Therapy Market Demand, Statistics, Future Growth and Outlook 2025-2032 | Mustang Bio, Fate Therapeutics - openPR
Mustang Bio stock plunges to 52-week low of $1.43 By Investing.com - Investing.com Australia
Mustang Bio stock plunges to 52-week low of $1.43 - Investing.com India
Mustang Bio Stock Price, Quotes and Forecasts | NASDAQ:MBIO - Benzinga
Mustang Bio Regains Nasdaq Compliance, Secures Position For Cell Therapy Advancements - Nasdaq
Mustang Bio meets Nasdaq’s equity listing requirements By Investing.com - Investing.com Canada
Mustang Bio meets Nasdaq’s equity listing requirements - Investing.com India
Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement - The Manila Times
MBIOMustang Bio Latest Stock News & Market Updates - StockTitan
BRIEF—Mustang Bio sells assets; focuses on MB-109, MB-108 and MB-101 - The Pharma Letter
Mustang Bio (MBIO) Projected to Post Earnings on Monday - Defense World
Mustang Bio stock plunges 29% on lease termination news - MSN
Mustang Bio stock plunges to 52-week low at $2 By Investing.com - Investing.com Australia
Mustang Bio stock plunges to 52-week low at $2 - Investing.com
Mustang Bio exits Worcester facility, sells assets to AbbVie By Investing.com - Investing.com Australia
Mustang Bio stock plunges 29% on lease termination news (MBIO:NASDAQ) - Seeking Alpha
Mustang Bio exits lease for Massachusetts facility, divests equipment - TipRanks
Mustang Bio to Exit Lease of Worcester, Mass. Manufacturing Facility -February 27, 2025 at 05:49 pm EST - Marketscreener.com
Mustang Bio to Exit Lease of Worcester, Mass. Manufacturing Facility - MarketWatch
Mustang Bio exits Worcester facility, sells assets to AbbVie - Investing.com
Mustang Bio Announces Sale of Fixed Assets and Exit of Facility - The Manila Times
Can Mustang Bio's $3M Financial Boost From Facility Exit Revitalize Its Cancer Therapy Pipeline? - StockTitan
Mustang Bio secures shareholder nod for warrant share issuance By Investing.com - Investing.com South Africa
Mustang Bio secures shareholder nod for warrant share issuance - Investing.com India
CI Financial Corp (CIX:CA): Stock Forecast and Q4 2024 Earnings Report - The Globe and Mail
Mustang Bio stock plunges to 52-week low of $2.6 amid sharp decline - Investing.com Australia
Mustang Bio sells assets and ends lease with AbbVie - MSN
Mustang Bio Sells Assets to AbbVie, Transfers Lease - TipRanks
Mustang Bio stock plunges to 52-week low of $2.6 amid sharp decline By Investing.com - Investing.com South Africa
Mustang Bio sells assets and ends lease with AbbVie By Investing.com - Investing.com UK
Mustang Bio regains compliance with Nasdaq minimum bid price requirement - MSN
Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement - The Manila Times
Mustang Bio, Inc. Regains Compliance with Nasdaq Listing Requirements Following Recent Public Offering - Nasdaq
Nasdaq Compliance Alert: Mustang Bio Clears Major Hurdle with $2.5M Equity Milestone - StockTitan
Mustang Bio Closes $8 Million Public Offering - citybiz
Mustang Bio, Inc. Completes Public Offering, Raising Approximately $8 Million for Cancer Cell Therapy Development - Nasdaq
Mustang Bio Announces Closing of $8 Million Public Offering - GlobeNewswire
Mustang Bio (MBIO) Secures Critical $8M Financing Through Strategic Share Offering - StockTitan
Mustang Bio sets terms for $8M public offering - MSN
1.39%
0.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):